MOH

Rating neutralTentativeAI Memo

Molina Healthcare

As of 2026-08-03/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-03 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q2 results raised FY2026 earnings guidance • 2026-07-22

Base target: $205 / p=50% prob

Biggest risk

Premium revenue declined 6%, membership fell materially, consolidated MCR increased to 92.2% from 90.4%, and Marketplace MCR exceeded expectations. Guidance also embeds Florida implementation and MAPD losses [#SEC-8K-2026-07-22].

Invalidation

Break below $165 or thesis failure.

What would change my mind?

The guidance increase, Medicaid performance in line with expectations, better-than-expected Medicare MCR, operating discipline, and $788 million of first-half operating cash flow support stabilization and possible 2027 recovery [#SEC-8K-2026-07-22].

Research note

Recommendation

neutral

Confidence

medium

As of

2026-08-03

Base target

$205

p=50%

Bull target

$230

p=25%

Bear target

$165

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Marketplace MCR and membership trajectory
Potential 2027 Medicaid margin recovery
The guidance increase, Medicaid performance in line with expectations, better-than-expected Medicare MCR, operating discipline, and $788 million of first-half operating cash flow support stabilization and possible 2027 recovery [#SEC-8K-2026-07-22].

BearKey bullets

Elevated medical-cost ratios, especially in Marketplace, could offset Medicaid improvement.
Membership contraction and lower premium revenue could persist.
Post-earnings analyst revision evidence remains unavailable despite the high-coverage classification.

WatchKey bullets

Q2 results raised FY2026 earnings guidance

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $205 (p=50%)

Target spread vs base: +12% / -20%

Scenario probabilities

Bull Target: $230 (p=25%)Base Target: $205 (p=50%)Bear Target: $165 (p=25%)

Commentary

News tone is mixed-to-negative: coverage emphasizes lower profit, lower revenue, and membership declines, while the company raised FY2026 earnings guidance. Social coverage and reliable post-print price attribution are unavailable, and analyst revision data are missing; confidence therefore remains moderate.

As of 2026-08-03 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Marketplace MCR and membership trajectory
Potential 2027 Medicaid margin recovery

Scenarios

Bull Target (Scenario probability)

$230 / p=25% prob

Base Target (Scenario probability)

$205 / p=50% prob

Bear Target (Scenario probability)

$165 / p=25% prob

Analysis 2026-08-03 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.35

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-07-22
Q2 results raised FY2026 earnings guidance
Q2 adjusted EPS was $1.51, premium revenue fell 6% year over year, and management raised adjusted FY2026 EPS guidance to at least $5.25. Medicaid performed in line with expectations, while Marketplace MCR was weaker [#SEC-8K-2026-07-22].
Prob 100.00% • Move 4.00% • Priced-in 75.00%
EVENT2026-12-31
FY2026 guidance delivery and Florida Medicaid implementation
FY2026 guidance includes a $1.50 per-share loss related to implementation of the new Florida Medicaid contract in Q4 2026. Year-end results should test delivery against the increased adjusted EPS guidance of at least $5.25 [#SEC-8K-2026-07-22].
Prob 90.00% • Move -6.00% • Priced-in 65.00%

Short-term Catalysts

Next few weeks

Marketplace MCR and membership trajectory
2026-11-01
The next quarterly operating update should clarify whether Marketplace acuity and risk-adjustment pressures persist. Q2 total membership declined to 4.926 million from 5.746 million year over year, and Marketplace MCR was 88.9% [#SEC-8K-2026-07-22].
Prob 70% • Move -7% • Priced-in 60%

Long-term Catalysts

Months to a year

Potential 2027 Medicaid margin recovery
2027-08-03
Management characterized 2026 as the trough year for Medicaid pretax margins and cited future rate increases as a path toward profitable growth in 2027; realization depends on rate adequacy, medical-cost control, and execution [#SEC-8K-2026-07-22].
Prob 50% • Move 18% • Priced-in 35%

Risks

Elevated medical-cost ratios, especially in Marketplace, could offset Medicaid improvement.
Membership contraction and lower premium revenue could persist.
Post-earnings analyst revision evidence remains unavailable despite the high-coverage classification.
The new Florida Medicaid contract carries a stated Q4 2026 earnings impact.
The projected 2027 margin recovery depends on future rate increases that are not assured.

Peers

Symbol	Summary
UNH	Direct managed-care comparator referenced in the packet's healthcare earnings context; useful for premium, membership, and medical-cost benchmarking, though business mix and scale differ.
ELV	Direct managed-care comparator referenced in the packet's healthcare earnings context; relevant for reimbursement, membership, and medical-cost comparisons, but not a perfect business match.
ENSG	Provider-side Medicaid and post-acute comparator; useful for utilization and reimbursement context but not a direct managed-care peer.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-03

Loading AI feed…

Symbol

Summary

UNH

Direct managed-care comparator referenced in the packet's healthcare earnings context; useful for premium, membership, and medical-cost benchmarking, though business mix and scale differ.

ELV

Direct managed-care comparator referenced in the packet's healthcare earnings context; relevant for reimbursement, membership, and medical-cost comparisons, but not a perfect business match.

ENSG

Provider-side Medicaid and post-acute comparator; useful for utilization and reimbursement context but not a direct managed-care peer.